Latest Arrhythmogenic right ventricular dysplasia Stories

Programming an implantable cardioverter-defibrillator (ICD) with a long-detection interval compared with a standard-detection interval resulted in a reduction in anti-tachycardia pacing episodes, ICD shocks delivered, and inappropriate shocks, according to a study in the May 8 issue of JAMA. "Therapy with ICDs is now the standard of care in primary and secondary prevention. As indications for implants have expanded, concern about possible adverse effects of ICD therapies on prognosis and...

redOrbit Staff & Wire Reports - Your Universe Online For the first time ever, researchers have been able to develop a maturation-based “disease-in-a-dish” model for an inherited heart ailment – a discovery that will help researchers study and test new therapies for the condition. Patients suffering from the condition, which is known as arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C), typically do not become aware that they have a heart problem until they are...

-Heart cells from patients with inherited heart muscle disease can now be studied in a petri dish without risk to patients, including the possibility of testing new treatments -Experiments performed on the cells show that the heart cell model matches that of the clinical features of arrhythmogenic right ventricular cardiomyopathy (ARVC), an inherited heart muscle disease associated with sudden cardiac death -Landmark study published in European Heart Journal, a top ranking international...

(Ivanhoe Newswire) -- 250,000 people in the U.S. die from sudden cardiac arrest every year. Now, a genetic variant in a cardiac protein could be linked to heart rhythm dysfunction. The gene identified by Vivek Singh, PhD, from the University of Cincinnati and colleagues is the first genetic variant in a calcium-binding protein found to be associated with ventricular arrhythmias and sudden cardiac death in dilated cardiomyopathy patients. Dialiated cardiomyopathy is a condition in which...

(Ivanhoe Newswire) – ARVD is an inherited cardiovascular disorder and one of the most common causes of sudden death in athletes and young healthy adults. A new study provides strategy for deciding which patients have greatest need for implanted defibrillator as a preventive measure in patients who have arrhythmogenic right ventricular dysplasia (ARVD) . In this study the researchers report that using criteria to assess the need ARVD patients had for a defibrilator they were able to...

NYU Langone Medical Center's Silvia G. Priori, M.D., Ph.D., co-lead author of expert consensus statement on the state of genetic testing for inherited cardiac conditionsAn international panel of experts from The Heart Rhythm Society and the European Heart Rhythm Association issued new guideline recommendations for all health care professionals about cardiovascular genetic testing at the Heart Rhythm Society's 32nd Annual Scientific Sessions.Silvia G. Priori, MD, PhD, a leader in the field of...

Researchers in Newfoundland have cracked the genetic code of a sudden death cardiac killer.As a result, they have developed a unique prevention program in which people with no symptoms, but with a suspect gene and a family history, are being implanted with internal cardiac defibrillators (ICDs) which can restart their hearts if they stop."Our discovery has led to a targeted genetic screening and individualized therapy that is significantly improving survival rates," Dr. Sean Connors...

(Ivanhoe Newswire) -- The genetic code of sudden cardiac death has been cracked. Now, people are able to be genetically screened for sudden cardiac death based on genes and family history, even if they've had no symptoms. The patients are recommended to receive internal cardiac defibrillators (ICDs) implanted to shock their heart if it stops beating."Our discovery has led to a targeted genetic screening and individualized therapy that is significantly improving survival rates," Dr....

SAN JOSE, Calif., Feb. 4 /PRNewswire-FirstCall/ -- NewCardio, Inc., (OTC Bulletin Board: NWCI) a cardiac diagnostic technology provider, announced today that its Chief Medical Officer, Ihor Gussak MD, PhD, FACC, world-recognized expert in electrocardiology and cardiac safety, will provide a special lecture at the prestigious Japanese Idiopathic Ventricular Fibrillation (J-IVFS) Annual Meeting at the Sankei Plaza convention center in Tokyo, Japan on February 8, 2010. Dr. Gussak's...

Clinical Data, a biotechnology company, has announced that its PGxHealth division has launched a new genetic test for arrhythmogenic right ventricular cardiomyopathy, an inherited and often fatal heart condition. The Familion arrhythmogenic right ventricular cardiomyopathy (ARVC) test is a complex genetic test that sequences the five genes most commonly associated with ARVC (PKP2, DSP, DSG2, DSC2 and TMEM43) and is performed in a CLIA-certified commercial laboratory that meets all applicable...